换一批
换一批
第一作者：
Hirotaka,Iwaki
第一单位：
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.;Data Tecnica International, Glen Echo, Maryland, USA.
作者：
Hirotaka,Iwaki [1]
;
Cornelis,Blauwendraat [2]
;
Hampton L,Leonard [1]
;
Mary B,Makarious [2]
;
Jonggeol J,Kim [2]
;
Ganqiang,Liu [3]
;
Jodi,Maple-Grødem [4]
;
Jean-Christophe,Corvol [5]
;
Lasse,Pihlstrøm [6]
;
Marlies,van Nimwegen [7]
;
Luba,Smolensky [8]
;
Ninad,Amondikar [8]
;
Samantha J,Hutten [8]
;
Mark,Frasier [8]
;
Khanh-Dung H,Nguyen [9]
;
Jacqueline,Rick [10]
;
Shirley,Eberly [11]
;
Faraz,Faghri [2]
;
Peggy,Auinger [12]
;
Kirsten M,Scott [13]
;
Ruwani,Wijeyekoon [13]
;
Vivianna M,Van Deerlin [14]
;
Dena G,Hernandez [2]
;
Raphael J,Gibbs [2]
;
Aaron G,Day-Williams [15]
;
Alexis,Brice [16]
;
Guido,Alves [17]
;
Alastair J,Noyce [18]
;
Ole-Bjørn,Tysnes [19]
;
Jonathan R,Evans [20]
;
David P,Breen [21]
;
Karol,Estrada [9]
;
Claire E,Wegel [22]
;
Fabrice,Danjou [23]
;
David K,Simon [24]
;
Ole A,Andreassen [25]
;
Bernard,Ravina [26]
;
Mathias,Toft [27]
;
Peter,Heutink [28]
;
Bastiaan R,Bloem [7]
;
Daniel,Weintraub [29]
;
Roger A,Barker [30]
;
Caroline H,Williams-Gray [31]
;
Bart P,van de Warrenburg [7]
;
Jacobus J,Van Hilten [32]
;
Clemens R,Scherzer [33]
;
Andrew B,Singleton [2]
;
Mike A,Nalls [1]
作者单位：
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.;Data Tecnica International, Glen Echo, Maryland, USA.
[1]
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
[2]
School of Medicine, Sun Yat-sen University, Guangzhou, China.;Advanced Center for Parkinson's Disease Research, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.;Precision Neurology Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
[3]
The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.;Department of Chemistry, Bioscience and Environmental Engineering, University in Stavanger, Stavanger, Norway.
[4]
Assistance-Publique Hôpitaux de Paris, ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France.
[5]
Department of Neurology, Oslo University Hospital, Oslo, Norway.
[6]
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands.
[7]
The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
[8]
Translational Genome Sciences, Biogen, Cambridge, Massachusetts, USA.
[9]
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
[10]
Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.
[11]
Department of Neurology, Center for Health + Technology, University of Rochester, Rochester, New York, USA.
[12]
Department of Clinical Neurosciences, University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK.
[13]
Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
[14]
Flagship Labs 60 Inc, Cambridge, Massachusetts, USA.;Statistical Genetics, Biogen, Cambridge, Massachusetts, USA.
[15]
Institut du cerveau et de la moelle épinière ICM, Paris, France.;Sorbonne Université SU, Paris, France.;INSERM UMR1127, Paris, France.
[16]
The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.;Department of Chemistry, Bioscience and Environmental Engineering, University in Stavanger, Stavanger, Norway.;Department of Neurology, Stavanger University Hospital, Stavanger, Norway.
[17]
Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.;Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.
[18]
Department of Neurology, Haukeland University Hospital, Bergen, Norway.;Department of Clinical Medicine, University of Bergen, Bergen, Norway.
[19]
Department of Neurology, Nottingham University NHS Trust, Nottingham, UK.
[20]
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK.;Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.;Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
[21]
Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, USA.
[22]
Institut du cerveau et de la moelle épinière ICM, Paris, France.
[23]
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.;Harvard Medical School, Boston, Massachusetts, USA.
[24]
NORMENT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.;Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
[25]
Voyager Therapeutics, Cambridge, Massachusetts, USA.;Department of Neurology, University of Rochester School of Medicine, Rochester, New York, USA.
[26]
Department of Neurology, Oslo University Hospital, Oslo, Norway.;Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
[27]
German Center for Neurodegenerative Diseases-Tubingen, Tuebingen, Germany.;HIH Tuebingen, Tuebingen, Germany.
[28]
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.;Department of Veterans Affairs, Philadelphia, Pennsylvania, USA.
[29]
Department of Clinical Neurosciences and WT-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
[30]
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
[31]
Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
[32]
Advanced Center for Parkinson's Disease Research, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.;Precision Neurology Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
[33]
主题词
日常生活活动(Activities of Daily Living);队列研究(Cohort Studies);疾病恶化(Disease Progression);女(雌)性(Female);人类(Humans);男(雄)性(Male);帕金森病(Parkinson Disease)
DOI
10.1002/mds.28312
PMID
33002231
发布时间
2022-10-05
- 浏览0
Movement disorders
Movement disorders
106-117页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
